Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-02-21 Option Award |
2025-02-24 4:15 pm |
N/A 2035-02-21 |
Voyager Therapeutics Inc. | VYGR | Jorgensen Nathan D. Chief Financial Officer |
154,500 | $0 | 234,500 (Direct) |
View |
| 2024-10-01 Option Award |
2024-10-02 4:09 pm |
N/A N/A |
Voyager Therapeutics Inc. | VYGR | Jorgensen Nathan D. Chief Financial Officer |
80,000 | $0 | 80,000 (Direct) |
View |
| 2024-07-08 Option Award |
2024-07-09 4:11 pm |
N/A 2034-07-08 |
Voyager Therapeutics Inc. | VYGR | Jorgensen Nathan D. Chief Financial Officer |
200,000 | $0 | 200,000 (Direct) |
View |
| 2024-05-06 Tax Withholding |
2024-05-07 4:15 pm |
N/A N/A |
Vor Biopharma Inc. | VOR | Jorgensen Nathan D. CHIEF FINANCIAL OFFICER |
834 | $1.75 | 189,403 (Direct) |
View |
| 2024-05-01 Tax Withholding |
2024-05-03 4:15 pm |
N/A N/A |
Vor Biopharma Inc. | VOR | Jorgensen Nathan D. CHIEF FINANCIAL OFFICER |
917 | $1.77 | 190,237 (Direct) |
View |
| 2024-03-01 Tax Withholding |
2024-03-05 4:15 pm |
N/A N/A |
Vor Biopharma Inc. | VOR | Jorgensen Nathan D. CHIEF FINANCIAL OFFICER |
6,310 | $2.27 | 191,154 (Direct) |
View |
| 2024-02-06 Tax Withholding |
2024-02-08 5:06 pm |
N/A N/A |
Vor Biopharma Inc. | VOR | Jorgensen Nathan D. CHIEF FINANCIAL OFFICER |
985 | $2.32 | 197,464 (Direct) |
View |
| 2024-01-29 Option Award |
2024-01-31 7:34 pm |
N/A 2034-01-28 |
Vor Biopharma Inc. | VOR | Jorgensen Nathan D. CHIEF FINANCIAL OFFICER |
150,000 | $0 | 298,449 (Direct) |
View |
| 2023-11-06 Tax Withholding |
2023-11-08 4:12 pm |
N/A N/A |
Vor Biopharma Inc. | VOR | Jorgensen Nathan D. Chief Financial Officer |
834 | $1.82 | 145,647 (Direct) |
View |
| 2023-09-01 Tax Withholding |
2023-09-06 4:31 pm |
N/A N/A |
Vor Biopharma Inc. | VOR | Jorgensen Nathan D. Chief Financial Officer |
6,310 | $2.67 | 146,481 (Direct) |
View |
| 2023-08-07 Tax Withholding |
2023-08-09 4:37 pm |
N/A N/A |
Vor Biopharma Inc. | VOR | Jorgensen Nathan D. Chief Financial Officer |
834 | $2.67 | 152,791 (Direct) |
View |
| 2023-05-08 Tax Withholding |
2023-05-10 4:16 pm |
N/A N/A |
Vor Biopharma Inc. | VOR | Jorgensen Nathan D. Chief Financial Officer |
834 | $4.14 | 153,625 (Direct) |
View |
| 2023-03-01 Tax Withholding |
2023-03-02 6:35 pm |
N/A N/A |
Vor Biopharma Inc. | VOR | Jorgensen Nathan D. Chief Financial Officer |
6,310 | $5.51 | 154,459 (Direct) |
View |
| 2023-02-06 Option Award |
2023-02-08 4:22 pm |
N/A 2033-02-05 |
Vor Biopharma Inc. | VOR | Jorgensen Nathan D. Chief Financial Officer |
136,500 | $0 | 251,769 (Direct) |
View |
| 2022-09-01 Option Award |
2022-09-06 4:14 pm |
N/A 2032-08-31 |
Vor Biopharma Inc. | VOR | Jorgensen Nathan D. Chief Financial Officer |
86,000 | $0 | 201,269 (Direct) |
View |
| 2022-02-01 Option Award |
2022-02-03 4:32 pm |
N/A 2032-01-31 |
Vor Biopharma Inc. | VOR | Jorgensen Nathan D. Chief Financial Officer |
135,000 | $0 | 135,000 (Direct) |
View |
| 2021-02-09 Conversion |
2021-02-09 5:22 pm |
N/A N/A |
Vor Biopharma Inc. | VOR | Jorgensen Nathan D. Chief Financial Officer |
51,610 | $0 | 29,269 (Direct) |
View |
Ownership |
2021-02-04 9:45 pm |
N/A N/A |
Vor Biopharma Inc. | VOR | Jorgensen Nathan D. Chief Financial Officer |
0 | $0 | 280,361 (Direct) |
View |